Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer

NCT05740566

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California Los Angeles Santa Monica, California, United States
View all 223 locations
View Trial Details
Active, not recruiting

Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)

NCT05609968

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Infirmary Cancer Care ( Site 0418) Mobile, Alabama, United States
  • Profound Research LLC ( Site 0444) Oceanside, California, United States
  • Clermont Oncology Center ( Site 0421) Clermont, Florida, United States
  • University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 0417) Miami, Florida, United States
View all 180 locations
View Trial Details
Active, not recruiting

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

NCT02201992

Conditions
ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Southern Cancer Center PC-Daphne Daphne, Alabama, United States
  • Southern Cancer Center PC-Mobile Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
View all 1618 locations
View Trial Details
Active, not recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

NCT04198766

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +56 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • California Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, not recruiting

A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

NCT05879822

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +36 more
Locations
  • Fundacao Pio Xii Hospital de Cancer de Barretos Barretos, Brazil
  • Cionc-Centro Integrado de Oncologia de Curitiba Curitiba, Brazil
  • Hospital Erasto Gaertner - Liga Paranaense de Combate Ao Câncer Curitiba, Brazil
  • Oncosite - Centro de Pesquisa Clinica E Oncologia Ijuí, Brazil
View all 54 locations
View Trial Details
Active, not recruiting

Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study

NCT06461338

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine. Guangzhou, Guangdong, China
  • Guangdong Provincial Hospital of Chinese Medicine Guangzhou, Guangdong, China
  • Jiangsu Provincial Hospital of Chinese Medicine Nanjing, Jiangsu, China
View Trial Details

Related conditions